VTN and cancer: Similar to the blood coagulation proteins, complement proteins, through their interactions with cells in the tumor microenvironment and metastasis-targeted organs, modulate tumor growth, anti-tumor immunity, angiogenesis, and thus overall malignancy progression and, possibly, cancer susceptibility to various therapies [80].